Selected research
Industry Research
Anti-worm Medication Industry Research Report 2026
Market perspective
The global Anti-worm Medication market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Anti-worm Medication is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Anti-worm Medication is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Anti-worm Medication is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Anti-worm Medication include Boehringer Ingelheim, Chanelle Group, Dechra, Elanco, Fredun Pharmaceuticals Ltd, K.A. Malle Pharmaceuticals, Lasa Supergenerics Limited, Salius Pharma and Sequent Scientific, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Anti-worm Medication market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Anti-worm Medication Market by Company
Boehringer Ingelheim
Chanelle Group
Dechra
Elanco
Fredun Pharmaceuticals Ltd
K.A. Malle Pharmaceuticals
Lasa Supergenerics Limited
Salius Pharma
Sequent Scientific
Supharma Chem
Vetoquinol
Virbac
Zoetis
Bayer
GlaxoSmithKline
Zhongjia Pharmaceutical
Huazhong Pharmaceutical
Jiangsu Qihui
Merck Animal Health
Anti-worm Medication Segment by Type
Albenza
Vermox
Anti-worm Medication Segment by Application
Human
Veterinary
Anti-worm Medication Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-worm Medication market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Anti-worm Medication and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-worm Medication.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Anti-worm Medication manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Anti-worm Medication by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Anti-worm Medication in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Albenza
- Vermox
Applications
- Human
- Veterinary
Companies covered
- Boehringer Ingelheim
- Chanelle Group
- Dechra
- Elanco
- Fredun Pharmaceuticals Ltd
- K.A. Malle Pharmaceuticals
- Lasa Supergenerics Limited
- Salius Pharma
- Sequent Scientific
- Supharma Chem
- Vetoquinol
- Virbac
- Zoetis
- Bayer
- GlaxoSmithKline
- Zhongjia Pharmaceutical
- Huazhong Pharmaceutical
- Jiangsu Qihui
- Merck Animal Health
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Anti-worm Medication Market Size (2021-2032)
- 2.2.2 Global Anti-worm Medication Sales (2021-2032)
- 2.2.3 Global Anti-worm Medication Market Average Price (2021-2032)
- 2.3 Anti-worm Medication by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Albenza
- 2.3.3 Vermox
- 2.4 Anti-worm Medication by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Human
- 2.4.3 Veterinary
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Anti-worm Medication Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Anti-worm Medication Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Anti-worm Medication Revenue of Manufacturers (2021-2026)
- 3.4 Global Anti-worm Medication Average Price by Manufacturers (2021-2026)
- 3.5 Global Anti-worm Medication Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Anti-worm Medication, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Anti-worm Medication, Product Type & Application
- 3.8 Global Manufacturers of Anti-worm Medication, Established Date
- 3.9 Global Anti-worm Medication Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Boehringer Ingelheim
- 4.1.1 Boehringer Ingelheim Company Information
- 4.1.2 Boehringer Ingelheim Business Overview
- 4.1.3 Boehringer Ingelheim Anti-worm Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Boehringer Ingelheim Anti-worm Medication Product Portfolio
- 4.1.5 Boehringer Ingelheim Recent Developments
- 4.2 Chanelle Group
- 4.2.1 Chanelle Group Company Information
- 4.2.2 Chanelle Group Business Overview
- 4.2.3 Chanelle Group Anti-worm Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Chanelle Group Anti-worm Medication Product Portfolio
- 4.2.5 Chanelle Group Recent Developments
- 4.3 Dechra
- 4.3.1 Dechra Company Information
- 4.3.2 Dechra Business Overview
- 4.3.3 Dechra Anti-worm Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Dechra Anti-worm Medication Product Portfolio
- 4.3.5 Dechra Recent Developments
- 4.4 Elanco
- 4.4.1 Elanco Company Information
- 4.4.2 Elanco Business Overview
- 4.4.3 Elanco Anti-worm Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Elanco Anti-worm Medication Product Portfolio
- 4.4.5 Elanco Recent Developments
- 4.5 Fredun Pharmaceuticals Ltd
- 4.5.1 Fredun Pharmaceuticals Ltd Company Information
- 4.5.2 Fredun Pharmaceuticals Ltd Business Overview
- 4.5.3 Fredun Pharmaceuticals Ltd Anti-worm Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Fredun Pharmaceuticals Ltd Anti-worm Medication Product Portfolio
- 4.5.5 Fredun Pharmaceuticals Ltd Recent Developments
- 4.6 K.A. Malle Pharmaceuticals
- 4.6.1 K.A. Malle Pharmaceuticals Company Information
- 4.6.2 K.A. Malle Pharmaceuticals Business Overview
- 4.6.3 K.A. Malle Pharmaceuticals Anti-worm Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 K.A. Malle Pharmaceuticals Anti-worm Medication Product Portfolio
- 4.6.5 K.A. Malle Pharmaceuticals Recent Developments
- 4.7 Lasa Supergenerics Limited
- 4.7.1 Lasa Supergenerics Limited Company Information
- 4.7.2 Lasa Supergenerics Limited Business Overview
- 4.7.3 Lasa Supergenerics Limited Anti-worm Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Lasa Supergenerics Limited Anti-worm Medication Product Portfolio
- 4.7.5 Lasa Supergenerics Limited Recent Developments
- 4.8 Salius Pharma
- 4.8.1 Salius Pharma Company Information
- 4.8.2 Salius Pharma Business Overview
- 4.8.3 Salius Pharma Anti-worm Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Salius Pharma Anti-worm Medication Product Portfolio
- 4.8.5 Salius Pharma Recent Developments
- 4.9 Sequent Scientific
- 4.9.1 Sequent Scientific Company Information
- 4.9.2 Sequent Scientific Business Overview
- 4.9.3 Sequent Scientific Anti-worm Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Sequent Scientific Anti-worm Medication Product Portfolio
- 4.9.5 Sequent Scientific Recent Developments
- 4.10 Supharma Chem
- 4.10.1 Supharma Chem Company Information
- 4.10.2 Supharma Chem Business Overview
- 4.10.3 Supharma Chem Anti-worm Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Supharma Chem Anti-worm Medication Product Portfolio
- 4.10.5 Supharma Chem Recent Developments
- 4.11 Vetoquinol
- 4.11.1 Vetoquinol Company Information
- 4.11.2 Vetoquinol Business Overview
- 4.11.3 Vetoquinol Anti-worm Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Vetoquinol Anti-worm Medication Product Portfolio
- 4.11.5 Vetoquinol Recent Developments
- 4.12 Virbac
- 4.12.1 Virbac Company Information
- 4.12.2 Virbac Business Overview
- 4.12.3 Virbac Anti-worm Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Virbac Anti-worm Medication Product Portfolio
- 4.12.5 Virbac Recent Developments
- 4.13 Zoetis
- 4.13.1 Zoetis Company Information
- 4.13.2 Zoetis Business Overview
- 4.13.3 Zoetis Anti-worm Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Zoetis Anti-worm Medication Product Portfolio
- 4.13.5 Zoetis Recent Developments
- 4.14 Bayer
- 4.14.1 Bayer Company Information
- 4.14.2 Bayer Business Overview
- 4.14.3 Bayer Anti-worm Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Bayer Anti-worm Medication Product Portfolio
- 4.14.5 Bayer Recent Developments
- 4.15 GlaxoSmithKline
- 4.15.1 GlaxoSmithKline Company Information
- 4.15.2 GlaxoSmithKline Business Overview
- 4.15.3 GlaxoSmithKline Anti-worm Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 GlaxoSmithKline Anti-worm Medication Product Portfolio
- 4.15.5 GlaxoSmithKline Recent Developments
- 4.16 Zhongjia Pharmaceutical
- 4.16.1 Zhongjia Pharmaceutical Company Information
- 4.16.2 Zhongjia Pharmaceutical Business Overview
- 4.16.3 Zhongjia Pharmaceutical Anti-worm Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Zhongjia Pharmaceutical Anti-worm Medication Product Portfolio
- 4.16.5 Zhongjia Pharmaceutical Recent Developments
- 4.17 Huazhong Pharmaceutical
- 4.17.1 Huazhong Pharmaceutical Company Information
- 4.17.2 Huazhong Pharmaceutical Business Overview
- 4.17.3 Huazhong Pharmaceutical Anti-worm Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.17.4 Huazhong Pharmaceutical Anti-worm Medication Product Portfolio
- 4.17.5 Huazhong Pharmaceutical Recent Developments
- 4.18 Jiangsu Qihui
- 4.18.1 Jiangsu Qihui Company Information
- 4.18.2 Jiangsu Qihui Business Overview
- 4.18.3 Jiangsu Qihui Anti-worm Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.18.4 Jiangsu Qihui Anti-worm Medication Product Portfolio
- 4.18.5 Jiangsu Qihui Recent Developments
- 4.19 Merck Animal Health
- 4.19.1 Merck Animal Health Company Information
- 4.19.2 Merck Animal Health Business Overview
- 4.19.3 Merck Animal Health Anti-worm Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.19.4 Merck Animal Health Anti-worm Medication Product Portfolio
- 4.19.5 Merck Animal Health Recent Developments
5 Global Anti-worm Medication Market Scenario by Region
- 5.1 Global Anti-worm Medication Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Anti-worm Medication Sales by Region: 2021-2032
- 5.2.1 Global Anti-worm Medication Sales by Region: 2021-2026
- 5.2.2 Global Anti-worm Medication Sales by Region: 2027-2032
- 5.3 Global Anti-worm Medication Revenue by Region: 2021-2032
- 5.3.1 Global Anti-worm Medication Revenue by Region: 2021-2026
- 5.3.2 Global Anti-worm Medication Revenue by Region: 2027-2032
- 5.4 North America Anti-worm Medication Market Facts & Figures by Country
- 5.4.1 North America Anti-worm Medication Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Anti-worm Medication Sales by Country (2021-2032)
- 5.4.3 North America Anti-worm Medication Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Anti-worm Medication Market Facts & Figures by Country
- 5.5.1 Europe Anti-worm Medication Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Anti-worm Medication Sales by Country (2021-2032)
- 5.5.3 Europe Anti-worm Medication Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Anti-worm Medication Market Facts & Figures by Country
- 5.6.1 Asia Pacific Anti-worm Medication Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Anti-worm Medication Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Anti-worm Medication Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Anti-worm Medication Market Facts & Figures by Country
- 5.7.1 South America Anti-worm Medication Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Anti-worm Medication Sales by Country (2021-2032)
- 5.7.3 South America Anti-worm Medication Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Anti-worm Medication Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Anti-worm Medication Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Anti-worm Medication Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Anti-worm Medication Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Anti-worm Medication Sales by Type (2021-2032)
- 6.1.1 Global Anti-worm Medication Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Anti-worm Medication Sales Market Share by Type (2021-2032)
- 6.2 Global Anti-worm Medication Revenue by Type (2021-2032)
- 6.2.1 Global Anti-worm Medication Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Anti-worm Medication Revenue Market Share by Type (2021-2032)
- 6.3 Global Anti-worm Medication Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Anti-worm Medication Sales by Application (2021-2032)
- 7.1.1 Global Anti-worm Medication Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Anti-worm Medication Sales Market Share by Application (2021-2032)
- 7.2 Global Anti-worm Medication Revenue by Application (2021-2032)
- 7.2.1 Global Anti-worm Medication Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Anti-worm Medication Revenue Market Share by Application (2021-2032)
- 7.3 Global Anti-worm Medication Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Anti-worm Medication Value Chain Analysis
- 8.1.1 Anti-worm Medication Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Anti-worm Medication Production Mode & Process
- 8.2 Anti-worm Medication Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Anti-worm Medication Distributors
- 8.2.3 Anti-worm Medication Customers
9 Global Anti-worm Medication Analyzing Market Dynamics
- 9.1 Anti-worm Medication Industry Trends
- 9.2 Anti-worm Medication Industry Drivers
- 9.3 Anti-worm Medication Industry Opportunities and Challenges
- 9.4 Anti-worm Medication Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst